StockData
PepGen Inc. logo

PepGen Inc. (PEPG) stock

PEPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$3.88−0.31 (-7.40%)

Close on Nov 17, 2026Market cap $268.73MP/E –Yield –

PepGen operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

PepGen's operating income for the twelve months ending Jun 30, 2026 was -$76.24M. For fiscal 2025 it was -$93.61M. The highest annual figure on record is -$27.11M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$93.61M–
FY2024Dec 31, 2024-$97.74M–
FY2023Dec 31, 2023-$84.77M–
FY2022Dec 31, 2022-$68.30M–
FY2021Dec 31, 2021-$27.11M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$18.94M–
Q1 FY2026Mar 31, 2026-$18.94M–
Q4 FY2025Dec 31, 2025-$19.71M–
Q3 FY2025Sep 30, 2025-$18.65M–
Q2 FY2025Jun 30, 2025-$23.93M–
Q1 FY2025Mar 31, 2025-$31.32M–
Q4 FY2024Dec 31, 2024-$24.35M–
Q3 FY2024Sep 30, 2024-$23.17M–
Q2 FY2024Jun 30, 2024-$30.43M–
Q1 FY2024Mar 31, 2024-$19.80M–
Q4 FY2023Dec 31, 2023-$20.81M–
Q3 FY2023Sep 30, 2023-$24.78M–
Q2 FY2023Jun 30, 2023-$21.14M–
Q1 FY2023Mar 31, 2023-$18.03M–
Q4 FY2022Dec 31, 2022-$17.21M–
Q3 FY2022Sep 30, 2022-$19.55M–
Q2 FY2022Jun 30, 2022-$17.64M–
Q1 FY2022Mar 31, 2022-$13.89M–
Q4 FY2021Dec 31, 2021-$7.21M–
Q3 FY2021Sep 30, 2021-$8.08M–
Q2 FY2021Jun 30, 2021-$5.19M–
Q1 FY2021Mar 31, 2021-$6.63M–

More PepGen figures

See a number that looks wrong?